Efficacy of purslane in the treatment of oral lichen planus

Phytotherapy Research

Volumn 24, Issue 2, 2010, Pages 240-244

  Agha Hosseini, Farzaneh ^a   Borhan Mojabi, Katayun ^b   Monsef Esfahani, Hamid Reza ^c   Mirzaii Dizgah, Iraj ^d   Etemad Moghadam, Shahroo ^a   Karagah, Aida ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical trial; Herbal medicine; Oral lichen planus; Purslane; Treatment; Visual analog scale

Indexed keywords

HERBACEOUS AGENT; PLACEBO; PURSLANE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LICHEN PLANUS; MALE; PATIENT ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PORTULACA; TREATMENT OUTCOME;

PORTULACACEAE;

EID: 75849139756     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2919     Document Type: Article

References (31)

1. Aghahosseini F, Arbabi-Kalati F, Fashtami LA, Djavid GE, Fateh M, Beitollahi JM. 2006. Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Lasers Surg Med 38: 33-38.
2. Baudet-Pommel M, Janin-Mercier A, Souteyrand P. 1991. Sequential immunopathologic study of oral lichen planus treated with tretinoin and etretinate. Oral Surg Oral Med Oral Pathol 71: 197-202.
3. Bauzá A, España A, Gil P, Lloret P, Vázquez Doval FJ. 2005. Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol 44: 158-162.
4. Bouquot JE, Gorlin RJ. 1986. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 61: 373-381.
5. Buajeeb W, Kraivaphan P, Pobrurksa C. 1997. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83: 21-25.
6. Carrozzo M, Gandolfo S. 1999. The management of oral lichen planus. Oral Dis 5: 196-205.
7. Carrozzo M, Uboldi de Capei M, Dametto E et al. 2004. Tumor necrosis factor alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122: 87-94.
8. Chaiyarit P, Ma N, Hiraku Y et al. 2005. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 96: 553-559.
9. Conrotto D, Carbone M, Carrozzo M et al. 2006. Ciclosporin vs clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol 154: 139-145.
10. Eisen D. 2002. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 46: 207-214.
11. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. 2005. Number V. Oral lichen planus: clinical features and management. Oral Dis 11: 338-349.
12. Fardet L, Kassar A, Cabane J, Flahault A. 2007. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 30: 861-881.
13. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. 2003. Th1 cytokines in oral lichen planus. J Oral Pathol Med 32: 77-83.
14. Lim YY, Quah EPL. 2007. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem 103: 734-740.
15. Movahedian A, Ghannadi A, Vashirnia M. 2007. Hypocholesterolemic effects of purslane extract on serum lipids in rabbits fed with high cholesterol levels. Int J Pharmacol 3: 285-289.
16. Nagao T, Warnakulasuriya S, Ikeda N et al. 2001. Serum antioxidant micronutrient levels in oral lichen planus. J Oral Pathol Med 30: 264-267.
17. Niwa Y, Terashima T, Sumi H. 2003. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 149: 960-967.
18. Pawson BA, Ehmann CW, Itri LM, Sherman MI. 1982. Retinoids at the threshold: their biological significance and therapeutic potential. J Med Chem 25: 1269-1277.
19. Sander CS, Cooper SM, Ali I, Dean D, Thiele JJ, Wojnarowska F. 2005. Decreased antioxidant enzyme expression and increased oxidative damage in erosive lichen planus of the vulva. BJOG 112: 1572-1575.
20. Scott J, Huskisson EC. 1976. Graphic representation of pain. Pain 2: 175-184.
21. Scully C, Beyli M, Ferreiro MC et al. 1998. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9: 86-122.
22. Scully C, Eisen D, Carrozzo M. 2000. Management of oral lichen planus. Am J Clin Dermatol 1: 287-306.
23. Sezer E, Ozugurlu F, Ozyurt H, Sahin S, Etikan I. 2007. Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol 32: 430-434.
24. Simopoulos AP, Tan DX, Manchester LC, Reiter RJ. 2005. Purslane: a plant source of omega-3 fatty acids and melatonin. J Pineal Res 39: 331-332.
25. Sun A, Chia JS, Chang YF, Chiang CP. 2002. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med 31: 196-203.
26. Thongprasom K, Chaimusig M, Korkij W, Sererat T, Luangjarmekorn L, Rojwattanasirivej S. 2007. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med 36: 142-146.
27. Thongprasom K, Luangjarmekorn L, Sererat T, Taweesap W. 1992. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 21: 456-458.
28. van der Meij EH, van der Waal I. 2003. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32: 507-512.
29. Wilson E. 1869. On lichen planus. J Cutan Med Dis Skin 3: 117-132.
30. Xiang L, Xing D, Wang W, Wang R, Ding Y, Du L. 2005. Alkaloids from Portulaca oleracea L. Phytochemistry 66: 2595-2601.
31. Xiao FY, Lu FE, Xu LJ. 2005. Effect of different parts of Portulaca oleracea on the levels of TNF-alpha and IL-6 in the supernatant of cultured adipose cell. Zhongguo Zhong Yao Za Zhi 30: 1763-1766 [Abstract only].